AbstractThe prevalence of hypertension in sub-Saharan Africa is high and it is the main driver for cardiovascular diseases in the region. Cardiovascular diseases are associated with high morbidity and mortality worldwide. The high prevalence of hypertension in sub-Saharan Africa (SSA) can be attributed to rural-urban migration, high salt intake, smoking of tobacco and inadequate exercise. Awareness and control of hypertension is generally low with women having better control rates as compared to men. Untreated hypertension is associated with stroke, myocardial infarction and renal failure. The management of hypertension in the sub region is a major challenge due to financial constraints and inadequate resources. Hypertension is struggling to gain priority as a major health threat as infectious diseases like Human Immunodeficiency virus (HIV), tuberculosis (TB) and malaria are the main focus of most public health institutions. Hypertension is largely preventable and can be easily controlled using evidence based practices such as regular exercises, decreasing salt intake, cessation of smoking and alcohol intake and the usage of antihypertensives.Non-communicable diseases such as hypertension are rapidly overtaking communicable diseases in the sub-Saharan region and pose a major health threat. There is a need to prioritize cardiovascular diseases with a focus on pragmatic prevention and control of hypertension in order to decrease the burden of the disease in the region.
Lim SS,Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990– 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. Lancet;380(9859):2224–60.
Brundtland GH. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.
Global status report on noncommunicable diseases 2014 [Internet]. Geneva: World Health Organization; 2014. Available from: .(http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf
A global brief on hypertension. Silent killer, global public health crisis [Internet]. Geneva: World Health Organization; Available from: http://apps.who. int/iris/bitstream/10665/79059/1/WHO_DCO_ WHD_2013.2_eng.pdf
Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Geneva World Health Organ [Internet]. 2007; Available from: http:// www.who.int/cardiovascular_diseases/guidelines
Gaziano TA. Cardiovascular Disease in the Developing World and Its Cost-Effective Management. Circulation. 2005 Dec 6;112(23):3547–53.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. The Lancet. 2006 May;367(9524):1747–57.
Bygbjerg IC. Double burden of noncommunicable and infectious diseases in developing countries. Science. 2012 Sep 21;337(6101):1499–501.
Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation. 2005 Dec 6;112(23):3562–8.
de-Graft Aikins A, Unwin N, Agyemang C, Allotey P, Campbell C, Arhinful D. Tackling Africa’s chronic disease burden: from the local to the global. Glob Health. 2010;6:5.
WHO | Preventing chronic diseases: a vital investment. WHO. Available from: http://www.who.int/chp/chronic_disease_report/en/
Walker RW, McLarty DG, Kitange HM, Whiting D, Masuki G, Mtasiwa DM, et al. Stroke mortality in urban and rural Tanzania. Adult Morbidity and Mortality Project. Lancet Lond Engl. 2000 May 13;355(9216):1684–7.
Mensah GA. Epidemiology of stroke and high blood pressure in Africa. Heart Br Card Soc. 2008 Jun;94(6):697–705.
Ogah OS, Rayner BL. Recent advances in hypertension in sub-Saharan Africa. Heart Br Card Soc. 2013 Oct;99(19):1390–7.
Addo J, Smeeth L, Leon DA. Hypertension In Sub-Saharan Africa A Systematic Review. Hypertension. 2007 Dec 1;50(6):1012–8.
Kayima J, Wanyenze RK, Katamba A, Leontsini E, Nuwaha F. Hypertension awareness, treatment and control in Africa: a systematic review. BMC Cardiovasc Disord. 2013;13:54.
Muluneh AT, Haileamlak A, Tessema F, Alemseged F, Woldemichael K, Asefa M, et al. Population based survey of chronic non-communicable diseases at gilgel gibe field research center, southwest ethiopia. Ethiop J Health Sci. 2012 Aug;22(S):7–18.
Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N. Hypertension prevalence, awareness, treatment, and control in mozambique: urban/rural gap during epidemiological transition. Hypertension. 2009 Jul;54(1):77–83.
Dewhurst MJ, Dewhurst F, Gray WK, Chaote P, Orega GP, Walker RW. The high prevalence of hypertension in rural-dwelling Tanzanian older adults and the disparity between detection, treatment and control: a rule of sixths? J Hum Hypertens. 2013 Jun;27(6):374–80.
Dalal S, Beunza JJ, Volmink J, Adebamowo C, Bajunirwe F, Njelekela M, et al. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol. 2011 Aug;40(4):885–901.
Mufunda E, Albin B, Hjelm K. Differences in health and illness beliefs in zimbabwean men and women with diabetes. Open Nurs J. 2012;6:117–25.
Hjelm K, Nambozi G. Beliefs about health and illness: a comparison between Ugandan men and women living with diabetes mellitus. Int Nurs Rev. 2008 Dec;55(4):434–41.
MacMahon S, Alderman MH, Lindholm LH, Liu L, Sanchez RA, Seedat YK. Blood-pressure-related disease is a global health priority. Lancet Lond Engl. 2008 May 3;371(9623):1480–2.
Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. Hypertension. 2015 Feb;65(2):291–8.
Gaziano TA, Bitton A, Anand S, Weinstein MC, International Society of Hypertension. The global cost of nonoptimal blood pressure. J Hypertens. 2009 Jul;27(7):1472–7.
Gu Q, Dillon CF, Burt VL, Gillum RF. Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension. Am J Hypertens. 2010 Jan;23(1):38–45.
He FJ, MacGregor GA. Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens. 2003 Jul;17(7):455–7.
Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull. 1994 Apr;50(2):272–98.
Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet Lond Engl. 2000 Dec 9;356(9246):1955–64.
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (jnc 8). JAMA. 2014 Feb 5;311(5):507–20.
Cheung BMY, Li C. Diabetes and Hypertension: Is There a Common Metabolic Pathway? Curr Atheroscler Rep. 2012 Apr;14(2):160–6.
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015 Nov 26;373(22):2103–16.
Hypertension Treatment & Management: Approach Considerations, Nonpharmacologic Therapy, Pharmacologic Therapy. 2015 Sep 18; Available from: http://emedicine.medscape.com
Whelton PK, Appel LJ, Sacco RL, Anderson CAM, Antman EM, Campbell N, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012 Dec 11;126(24):2880–9.
Ganann R, Fitzpatrick-Lewis D, Ciliska D, Peirson LJ, Warren RL, Fieldhouse P, et al. Enhancing nutritional environments through access to fruit and vegetables in schools and homes among children and youth: a systematic review. BMC Res Notes. 2014;7:422.
WHO. WHO guideline for screening of cardiovascular risk including diabetes. Geneva: World Health Organization. 2014;
Lawson KD, Fenwick E a. L, Pell ACH, Pell JP. Comparison of mass and targeted screening strategies for cardiovascular risk: simulation of the effectiveness, cost-effectiveness and coverage using a cross-sectional survey of 3921 people. Heart Br Card Soc. 2010 Feb;96(3):208–12.
Baker J, Mitchell R, Lawson K, Pell J. Ethnic differences in the cost-effectiveness of targeted and mass screening for high cardiovascular risk in the UK: cross-sectional study. Heart Br Card Soc. 2013 Dec;99(23):1766–71.
WHO. Affordable technology. Blood pressure measuring devices for low resource settings. Geneva: World Health Organization; 2005.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.